HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Fumigant 93 (D-D)

mixture of 1,3-dichloropropane & 1,3-dichloropropene; may also contain epichlorohydrin; RN given refers to 1,3-dichloro cpd
Also Known As:
D-D; D-D mixture
Networked: 408 relevant articles (8 outcomes, 35 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Jeong, Jae-Wook: 6 articles (12/2013 - 05/2009)
2. DeMayo, Francesco J: 6 articles (07/2013 - 05/2009)
3. Lydon, John P: 5 articles (07/2013 - 05/2009)
4. Palareti, Gualtiero: 5 articles (01/2010 - 05/2005)
5. Cosmi, Benilde: 5 articles (01/2010 - 05/2005)
6. Fodor, L: 5 articles (01/2005 - 08/2000)
7. Somogyvári, F: 5 articles (01/2005 - 08/2000)
8. Szabó, M: 5 articles (01/2005 - 08/2000)
9. Szolnoki, Z: 5 articles (01/2005 - 08/2000)
10. Legnani, Cristina: 4 articles (01/2010 - 05/2005)

Related Diseases

1. Venous Thrombosis (Deep-Vein Thrombosis)
2. Myocardial Infarction
3. Venous Thromboembolism
4. Hypertension (High Blood Pressure)
5. Thrombosis (Thrombus)
09/01/2011 - "The modified plasma protamine paracoagulation test has a higher sensitivity than plasma protamine paracoagulation test and a higher specificity than D-D test, and can be helpful in early diagnosis of thrombosis and fibrinolysis."
11/01/2003 - "The deletion/deletion (D/D) genotype of the angiotensin converting enzyme (ACE) has been purported to be a risk for post-operative thrombosis.This"
01/01/2010 - "In recent studies, markers for the assessment of the individual risk for recurrent thrombosis have been proposed, which can be of help to establish the optimal duration of VKA treatment; among them, the D-dimer (D-d) assay and the Residual Vein Thrombosis (RVT) assessment by Compression Ultra-Sonography (CUS) were shown to be the most suitable. "
12/01/1996 - "In the light of these results the authors affirm that: high fibrinogen and factor VII levels are highly prognostic for thrombosis in patients with deep venous thrombosis; the importance of the lack of inhibitory factors (AT III, PC, PS) is confined to individual genetically predisposed cases; there is an efficacious hyperfibrinolytic reactive response to the presence of thrombus (increase in tPA and D-D, reduction of PAI-1)."
12/01/1994 - "In patients with AAA, the levels of fibrin/fibrinogen degradation products (FDP) (11.4 +/- 20.1 micrograms/ml), thrombin-antithrombin III complex (TAT) (22.0 +/- 21.8 micrograms/l), plasmin-alpha 2 plasmin inhibitor complex (PIC) (2.6 +/- 2.9 micrograms/ml) and d-dimer of cross-linked fibrin degradation products (D-D) (8.4 +/- 10.8 micrograms/ml) were elevated, particularly when the AAAs had a large mural thrombus surface area or were accompanied by aneurysm of the iliac or femoral artery. "

Related Drugs and Biologics

1. Plasminogen Activator Inhibitor 1
2. K-3050
3. d,d-T80-prallethrin (ETOC)
4. fibrin fragment D (D-dimer)
5. Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
6. Fibrinogen (Factor I)
7. Carbon Monoxide
8. formycin diphosphate (FDP)
9. Fibrin
10. antithrombin III-protease complex

Related Therapies and Procedures

1. Caloric Restriction
2. Dilatation and Curettage (D&C)
3. Transplants (Transplant)
4. Homologous Transplantation (Allograft)
5. Aftercare (After-Treatment)